Your browser doesn't support javascript.
loading
Cathepsin S Alterations Induce a Tumor-Promoting Immune Microenvironment in Follicular Lymphoma.
Bararia, Deepak; Hildebrand, Johannes A; Stolz, Sebastian; Haebe, Sarah; Alig, Stefan; Trevisani, Christopher P; Osorio-Barrios, Francisco; Bartoschek, Michael D; Mentz, Michael; Pastore, Alessandro; Gaitzsch, Erik; Heide, Michael; Jurinovic, Vindi; Rautter, Katharina; Gunawardana, Jay; Sabdia, Muhammed B; Szczepanowski, Monika; Richter, Julia; Klapper, Wolfram; Louissaint, Abner; Ludwig, Christina; Bultmann, Sebastian; Leonhardt, Heinrich; Eustermann, Sebastian; Hopfner, Karl-Peter; Hiddemann, Wolfgang; von Bergwelt-Baildon, Michael; Steidl, Christian; Kridel, Robert; Tobin, Joshua W D; Gandhi, Maher K; Weinstock, David M; Schmidt-Supprian, Marc; Sárosi, Menyhárt B; Rudelius, Martina; Passerini, Verena; Mautner, Josef; Weigert, Oliver.
Afiliação
  • Bararia D; Department of Medicine III, Laboratory for Experimental Leukemia and Lymphoma Research (ELLF), Hospital of the Ludwig-Maximilians-University (LMU), Munich, Bavaria 81377, Germany; German Cancer Consortium (DKTK), Munich, Bavaria 81377, Germany; German Cancer Research Center (DKFZ), Heidelberg, Baden
  • Hildebrand JA; Department of Medicine III, Laboratory for Experimental Leukemia and Lymphoma Research (ELLF), Hospital of the Ludwig-Maximilians-University (LMU), Munich, Bavaria 81377, Germany; German Cancer Consortium (DKTK), Munich, Bavaria 81377, Germany; German Cancer Research Center (DKFZ), Heidelberg, Baden
  • Stolz S; Department of Medicine III, Laboratory for Experimental Leukemia and Lymphoma Research (ELLF), Hospital of the Ludwig-Maximilians-University (LMU), Munich, Bavaria 81377, Germany.
  • Haebe S; Department of Medicine III, Laboratory for Experimental Leukemia and Lymphoma Research (ELLF), Hospital of the Ludwig-Maximilians-University (LMU), Munich, Bavaria 81377, Germany.
  • Alig S; Department of Medicine III, Laboratory for Experimental Leukemia and Lymphoma Research (ELLF), Hospital of the Ludwig-Maximilians-University (LMU), Munich, Bavaria 81377, Germany.
  • Trevisani CP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Osorio-Barrios F; Institute of Experimental Hematology, TranslaTUM, Klinikum rechts der Isar, Technical University of Munich, Munich, Bavaria 81675, Germany.
  • Bartoschek MD; Department of Biology II, Center for Integrated Protein Science Munich (CIPSM), Ludwig-Maximilians-University (LMU), Munich, Bavaria 81377, Germany.
  • Mentz M; Department of Medicine III, Laboratory for Experimental Leukemia and Lymphoma Research (ELLF), Hospital of the Ludwig-Maximilians-University (LMU), Munich, Bavaria 81377, Germany.
  • Pastore A; Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Gaitzsch E; Department of Medicine III, Laboratory for Experimental Leukemia and Lymphoma Research (ELLF), Hospital of the Ludwig-Maximilians-University (LMU), Munich, Bavaria 81377, Germany; German Cancer Consortium (DKTK), Munich, Bavaria 81377, Germany; German Cancer Research Center (DKFZ), Heidelberg, Baden
  • Heide M; Department of Medicine III, Laboratory for Experimental Leukemia and Lymphoma Research (ELLF), Hospital of the Ludwig-Maximilians-University (LMU), Munich, Bavaria 81377, Germany; German Cancer Consortium (DKTK), Munich, Bavaria 81377, Germany; German Cancer Research Center (DKFZ), Heidelberg, Baden
  • Jurinovic V; Department of Medicine III, Laboratory for Experimental Leukemia and Lymphoma Research (ELLF), Hospital of the Ludwig-Maximilians-University (LMU), Munich, Bavaria 81377, Germany; Institute for Medical Information Processing, Biometry, and Epidemiology, Munich, Bavaria 81377, Germany.
  • Rautter K; Immunoanalytics: Research Group Tissue Control of Immunocytes & Core Facility, German Research Center for Environmental Health, Helmholtz Zentrum München, Munich, Bavaria 81377, Germany.
  • Gunawardana J; Blood Cancer Research Group, Mater Research, University of Queensland, Translational Research Institute, Brisbane, QLD 4101, Australia.
  • Sabdia MB; Blood Cancer Research Group, Mater Research, University of Queensland, Translational Research Institute, Brisbane, QLD 4101, Australia.
  • Szczepanowski M; Hematopathology Section, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Schleswig-Holstein 24105, Germany.
  • Richter J; Hematopathology Section, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Schleswig-Holstein 24105, Germany.
  • Klapper W; Hematopathology Section, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Schleswig-Holstein 24105, Germany.
  • Louissaint A; Massachusetts General Hospital, Department of Pathology, Boston, MA 02114, USA.
  • Ludwig C; Bavarian Center for Biomolecular Mass Spectrometry (BayBioMS), Technical University of Munich, Munich, Bavaria 85354, Germany.
  • Bultmann S; Department of Biology II, Center for Integrated Protein Science Munich (CIPSM), Ludwig-Maximilians-University (LMU), Munich, Bavaria 81377, Germany.
  • Leonhardt H; Department of Biology II, Center for Integrated Protein Science Munich (CIPSM), Ludwig-Maximilians-University (LMU), Munich, Bavaria 81377, Germany.
  • Eustermann S; Gene Center, Ludwig-Maximilians-University, Munich, Bavaria 81377, Germany.
  • Hopfner KP; Gene Center, Ludwig-Maximilians-University, Munich, Bavaria 81377, Germany.
  • Hiddemann W; Department of Medicine III, Laboratory for Experimental Leukemia and Lymphoma Research (ELLF), Hospital of the Ludwig-Maximilians-University (LMU), Munich, Bavaria 81377, Germany; German Cancer Consortium (DKTK), Munich, Bavaria 81377, Germany; German Cancer Research Center (DKFZ), Heidelberg, Baden
  • von Bergwelt-Baildon M; Department of Medicine III, Laboratory for Experimental Leukemia and Lymphoma Research (ELLF), Hospital of the Ludwig-Maximilians-University (LMU), Munich, Bavaria 81377, Germany; German Cancer Consortium (DKTK), Munich, Bavaria 81377, Germany; German Cancer Research Center (DKFZ), Heidelberg, Baden
  • Steidl C; Center for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC V5Z 1L3, Canada.
  • Kridel R; Center for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC V5Z 1L3, Canada.
  • Tobin JWD; Blood Cancer Research Group, Mater Research, University of Queensland, Translational Research Institute, Brisbane, QLD 4101, Australia.
  • Gandhi MK; Blood Cancer Research Group, Mater Research, University of Queensland, Translational Research Institute, Brisbane, QLD 4101, Australia.
  • Weinstock DM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Schmidt-Supprian M; German Cancer Consortium (DKTK), Munich, Bavaria 81377, Germany; Institute of Experimental Hematology, TranslaTUM, Klinikum rechts der Isar, Technical University of Munich, Munich, Bavaria 81675, Germany.
  • Sárosi MB; Institute of Inorganic Chemistry, Faculty of Chemistry and Mineralogy, Leipzig University, Leipzig, Saxony 04103, Germany.
  • Rudelius M; Institute of Pathology, Ludwig-Maximilians-University (LMU), Munich, Bavaria 80337, Germany.
  • Passerini V; Department of Medicine III, Laboratory for Experimental Leukemia and Lymphoma Research (ELLF), Hospital of the Ludwig-Maximilians-University (LMU), Munich, Bavaria 81377, Germany; German Cancer Consortium (DKTK), Munich, Bavaria 81377, Germany; German Cancer Research Center (DKFZ), Heidelberg, Baden
  • Mautner J; Helmholtz Zentrum München & Techniqual University of Munich, Munich, Bavaria 81377, Germany.
  • Weigert O; Department of Medicine III, Laboratory for Experimental Leukemia and Lymphoma Research (ELLF), Hospital of the Ludwig-Maximilians-University (LMU), Munich, Bavaria 81377, Germany; German Cancer Consortium (DKTK), Munich, Bavaria 81377, Germany; German Cancer Research Center (DKFZ), Heidelberg, Baden
Cell Rep ; 31(5): 107522, 2020 05 05.
Article em En | MEDLINE | ID: mdl-32330423
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Catepsinas / Linfoma Folicular / Apresentação de Antígeno / Microambiente Tumoral Limite: Animals / Humans Idioma: En Revista: Cell Rep Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Catepsinas / Linfoma Folicular / Apresentação de Antígeno / Microambiente Tumoral Limite: Animals / Humans Idioma: En Revista: Cell Rep Ano de publicação: 2020 Tipo de documento: Article